JODY COOMER: Open Payments
NPI 1962863407 · LEBANON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$750 in 39 payments from 24 companies in 2025. Trend: 2023 $177 · 2024 $15 · 2025 $750
Food & beverage: $750
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $90 |
| Lilly USA, LLC | 4 | $72 |
| Tandem Diabetes Care, Inc. | 5 | $72 |
| Madrigal Pharmaceuticals | 2 | $53 |
| Corcept Therapeutics | 3 | $52 |
| Dexcom, Inc. | 1 | $35 |
| Edwards Lifesciences Corporation | 1 | $28 |
| Insulet Corporation | 2 | $28 |
| Merck Sharp & Dohme LLC | 1 | $25 |
| Abbott Laboratories | 1 | $24 |
Products named: MOUNJARO, t:slim X2 Insulin Pump with Control-IQ, REZDIFFRA, Korlym, Rybelsus, Ozempic, Dexcom G6 Transmitter, SAPIEN 3 Ultra RESILIA.
Industry payments across KY — which companies pay providers there.
